down arrow

Ishita Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE806D01016
  • NSEID:
  • BSEID: 524400
INR
82.20
-0.5 (-0.6%)
BSENSE

Apr 11, 12:30 PM

BSE+NSE Vol: 170

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Parmax Pharma
Ishita Drugs
Mankind Pharma
Caprolactam Chem
Phaarmasia
Hamps Bio
Saroja Pharma In
Why is Ishita Drugs & Industries Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 8.34%
  • Poor long term growth as Net Sales has grown by an annual rate of 0.73% and Operating profit at 7.86% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.79
2
Flat results in Dec 24
3
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Sideways on 08-Apr-25 and has generated 2.49% returns since then
  • A key technical factor - KST has been Bearish since 08 Apr 2025
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ishita Drugs for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Ishita Drugs
15.14%
0.26
59.30%
SENSEX
0.45%
0.04
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0.73%
EBIT Growth (5y)
7.86%
EBIT to Interest (avg)
0.79
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.62
Tax Ratio
24.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.53%
ROE (avg)
8.34%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
25
Industry P/E
33
Price to Book Value
2.49
EV to EBIT
16.85
EV to EBITDA
16.52
EV to Capital Employed
8.26
EV to Sales
1.13
PEG Ratio
0.77
Dividend Yield
NA
ROCE (Latest)
39.71%
ROE (Latest)
8.67%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
PBDIT(Q)

Highest at Rs 0.30 cr.

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Ishita Drugs
Operating Profit (PBDIT) - Quarterly
Highest at Rs 0.30 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)